International Journal of Women's Health and Reproduction Sciences

Home Aim and Scope Instructions to Authors Editorial Policies Editorial Board Authorship Agreement Form Open Access and Copyright

Jan 2021, Vol 9, Issue 1

CURRENT ISSUE ARCHIVE AHEAD OF PRINT / ACCEPTED ARTICLE MOST VIEWED ARTICLES NEWS RELATED LINKS

Advanced Search

For Author's & Reviewer's

Committee on Publication
Ethics (COPE) Flowchart

Recommendations for the Conduct

COPE: Reviewers

World Association of Medical Editors(WAME)

EQUATOR Resources : Reviewers

Poll

How do you find the scientific quality of the published articles on our web site?

Very good

Good

Fair

Bad

Very bad

Original Article
Serum Zinc: A Noninvasive Biomarker for the Prediction of Invasive Placentation
Zainab Abdulameer Jafaar¹, Reshed Zeki Obeid², Dina Akeel Salman¹
¹Department of Obstetrics and Gynecology, College of Medicine, Al-Mustansiriya University, Baghdad, Iraq ²Department of Obstetrics and Gynecology, College of Medicine, Al-Anbar University, Ramadi, Iraq
IJWHR 2021; 9: 035-041 DOI: 10.15296/ijwhr.2021.07 Viewed : 2147 times Downloaded : 1803 times. Keywords : Maternal serum zinc, Placenta accrete spectrum, Placenta previa
Full Text(PDF) \| Related Articles
Abstract

Objectives: Abnormally invasive placentation (AIP) is a challenging situation capable of complicating childbirth that has recently arisen, imposing a risk on maternal lives and well-being. The optimal management of this complication requires a valid antenatal diagnostic tool other than Doppler ultrasound (US). Of these, a handful of laboratory markers have been so far used for the antenatal detection of invasive placentation. This study sought to establish whether low maternal serum zinc (Zn) is related to AIP in women with placenta previa. Materials and Methods: Over a period of six years, a prospective study was performed, including 168 pregnant ladies with placenta previa of whom, 72 cases were diagnosed with placenta accrete (PA) spectrum using Doppler US. The serum Zn was measured in all participants, and each individual was followed up regarding intraoperative and postoperative outcomes. Results: A significantly lower serum Zn level was found in women having the PA spectrum (P < 0.001). At a level of 68 μg/dL, serum Zn was 79.2% sensitive, 95.8% specific, and had a comparable accuracy (88.7% vs. 89.3%) to color Doppler US in the identification of cases with PAS spectrum among those with placenta previa. Conclusions: Low maternal serum Zn level is associated with AIP among placenta previa cases. Thus, more studies are needed in the future to support the use of this technique in the antenatal detection of the PAS.